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Abstract: We describe the first report of RNA sequencing of 5' capped (Pol II) RNAs 
isolated from acutely hepatitis C virus (HCV) infected Huh 7.5 cells that provides a general 
approach to identifying differentially expressed annotated and unannotated genes that 
participate in viral-host interactions. We identified 100, 684, and 1,844 significantly 
differentially expressed annotated genes in acutely infected proliferative Huh 7.5 cells at 6, 
48, and 72 hours, respectively (fold change ≥ 1.5 and Bonferroni adjusted p-values < 0.05). 
Most of the differentially expressed genes (>80%) and biological pathways (such as 
adipocytokine, Notch, Hedgehog and NOD-like receptor signaling) were not identified by 
previous gene array studies. These genes are critical components of host immune, 
inflammatory and oncogenic pathways and provide new information regarding changes 
that may benefit the virus or mediate HCV induced pathology. RNAi knockdown studies of 
newly identified highly upregulated FUT1 and KLHDC7B genes provide evidence that 
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their gene products regulate and facilitate HCV replication in hepatocytes. Our approach 
also identified novel Pol II unannotated transcripts that were upregulated. Results further 
identify new pathways that regulate HCV replication in hepatocytes and suggest that our 
approach will have general applications in studying viral-host interactions in model 
systems and clinical biospecimens.  
Keywords: HCV; JFH-1; RNA-seq; gene expression; next generation sequencing; 5' cap; 
Huh 7.5; FUT1; KLHDC7B 
 
1. Introduction 
Chronic hepatitis C virus (HCV) infection is a major cause of chronic liver disease and 
hepatocellular carcinoma (HCC) worldwide [1–3]. The mainstay of treatment for chronic hepatitis C 
has been ribavirin and pegylated interferon-α that generally result in a 55% sustained viral response 
(clearance) in previously untreated patients [4–6]. While the addition of recently clinically tested HCV 
protease inhibitors and other direct-acting antiviral drugs have markedly improve the overall response 
to therapy in many patients, a significant proportion of patients with chronic hepatitis C remain unable 
to be treated with these regimens [4–6]. This includes patients who are intolerant of combinations of 
new antivirals or represent special cases, such as post liver transplant patients [4–6]. In addition, 
developing vaccines to HCV have been challenging [7]. A better understanding of HCV-host 
interactions is likely to have applications in developing better models of HCV infection and 
replication, improved antiviral therapies and vaccine strategies.  
To better understand early events in HCV infection, gene expression studies of in vitro acutely 
infected human cells have been performed. These studies have identified alterations in biologic 
pathways including TGF-beta signaling, apoptosis, cellular metabolism, and oxidative stress [8–10]. 
Interestingly, interferon signaling and RIG-I signaling pathways were not represented in previous gene 
expression studies and it was thought that Huh 7.5 hepatoma cells were unable to produce a RIG-I 
response [8]. 
The goal of this study was to perform the most inclusive analysis of changes in Pol II RNAs, 
including mRNAs with short 3' pol(A) ends, primary miRNA transcripts and long noncoding RNAs 
that lack 3' poly(A) ends, during acute HCV infection of Huh 7.5 cells [11–13]. We have reported 
previously that the analysis of 5' capped RNA, rather than poly(A) selected RNA, provides a more 
sensitive means of detecting differentially expressed genes in HCV infected biospecimens [14]. Our 
approach purifies Pol II transcripts by binding their 5' caps with a high-affinity variant of the RNA cap 
binding protein (eIF4EK119A), enabling us to isolate and study transcripts with short or missing 
3' poly(A) ends [12,13,15–17]. This approach also identified a number of unannotated non-coding 
RNAs on chromosome 14 that are differentially expressed during chronic HCV infection [14]. These 
and other non-coding RNAs may be important in the host response to HCV infection or HCV 
replication as reported for miR122 [18–20]. 
In this study we used next generation RNA sequencing analysis of 5' capped RNA isolated from 
Huh 7.5 cells acutely infected in vitro with HCV to better characterize the early changes in hepatocyte Viruses 2012, 4  
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gene expression during HCV infection. These analyses provide new insights into HCV-induced 
changes in host gene expression, including identifying genes that might be important in viral 
replication, virus assembly, and hepatocellular carcinoma development in chronically infected HCV 
patients. Our results include RNAi knockdown studies of genes that are markedly upregulated during 
acute HCV infection and findings that their expression facilitates viral replication in vitro.  
2. Results 
2.1. HCV JFH-1 Infection of Huh 7.5 Cells 
Triplicate cultures of Huh 7.5 cells were infected with HCV JFH-1 for 2 hours with an MOI 
of 0.5 virions/cell. The acute infection of Huh 7.5 cells produced infectious virus and approximately 
40, 80, and 95 percent of cells were infected at 6, 48 and 72 hours, respectively, as measured by NS5A 
immunostaining. Control cells were mock infected at each time point. Pol II RNA transcripts 
(5' capped RNA) were isolated as previously described from total RNA recovered from infected and 
control cells after 6, 48 and 72 hours ([14], Experimental Procedures).  
2.2. RNA Sequencing (RNA-seq) Analysis of Annotated Gene Transcripts 
The 5' capped RNA samples from HCV infected and control cells were analyzed by RNA 
sequencing and data processed as described in Experimental Procedures. Bioinformatics analysis of the 
data identified 100, 684, and 1844 differentially expressed annotated genes in acutely infected, as 
compared to mock infected, Huh 7.5 cells at 6, 48, and 72 hours, respectively (fold change ≥ 1.50 and 
false discovery rate (FDR) > 13 (represents an untransformed FDR < 0.05 or 5 false positives out 
of 100) (Figure 1, Tables 1 and 2) [14]. 
Figure 1. Differentially expressed annotated genes after acute hepatitis C virus (HCV) 
infection of Huh 7.5  cells. A Venn diagram depicting the number of genes that are 
differentially expressed (FDR > 13 and fold change  1.5) at 6, 48, and 72 hours after HCV 
JFH-1 infection are shown. Genes that were significantly differentially expressed at more 
than one time point are shown in the overlapping regions. Viruses 2012, 4  
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Table 1. The 50 most highly upregulated genes during acute HCV infection. The USeq DefinedRegionScanSeqs (DRSS) application was used 
to count the sequence reads for each annotated gene and score them for differential expression. The scores were controlled by multiple testing 
and ranked by transformed false discovery rate (FDR) and fold change (Experimental procedures). An FDR of 20 represents an untransformed 
FDR of 0.01 or 1 false positive per 100 observations and an FDR of 50 represents an untransformed FDR of 0.00001 or 1 false positive per 
100,000 observations. Annotated genes that were significantly increased after acute HCV infection, relative to mock-infected cells, are 
presented in the order of their fold change. Newly identified differentially expressed genes are shown in bold. Genes marked with * had higher 
fold change at 48 h than at 72 h. A complete list of significantly upregulated genes is provided in Supplemental Table 1.  
Ensembl Gene ID  Gene Name  Description  Fold Change  FDR 
ENSG00000174951 FUT1  Fucosyltransferase  1  20.51  104.09 
ENSG00000130487  KLHDC7B  Kelch domain containing 7  18.93  141.94 
ENSG00000136826 KLF4 Kruppel-like  factor  4  15.10  142.63 
ENSG00000128591 FLNC  Filamin  C  13.38 1160.20 
ENSG00000148677  ANKRD1  Ankyrin repeat domain 1  12.06  351.26 
ENSG00000205595 AREG  Amphiregulin  11.63  229.81 
ENSG00000135842  C1orf24  Chromosome 1 open reading frame 24 (C1orf24)  7.23  63.37 
ENSG00000180535  MIST1  Xlass II bHLH protein MIST1  6.99  84.43 
ENSG00000136383 ALPK3  Alpha-kinase  3  6.83  202.42 
ENSG00000139269 INHBE  Inhibin,  beta  E  6.40  1324.33 
ENSG00000107731  UNC5B  Unc-5 homolog B (C. elegans)  6.17  265.31 
ENSG00000049323 LTBP1  Latent  transforming  growth factor beta binding protein 1  6.14  129.49 
ENSG00000048052 HDAC9  Histone  deacetylase  9  6.09  137.83 
ENSG00000198205  ZXDA  Zinc finger, X-linked, duplicated A  6.02  47.22 
ENSG00000111981  ULBP1  UL16 binding protein 1  6.01  37.66 
ENSG00000130513  GDF15  Growth differentiation factor 15  5.90  958.30 
ENSG00000122728  TAF1L  TAF1-like RNA polymerase II, TATA box binding protein (TBP)-associated factor  5.54  41.06 
ENSG00000138670  RASGEF1B  RasGEF domain family, member 1B  5.41  39.54 
ENSG00000176971  LOC387758  Similar to RIKEN cDNA 1110018M03  5.39  23.55 
ENSG00000160999  APS  Adaptor protein with pleckstrin homology and src homology 2 domains  5.18  22.09 Viruses 2012, 4  
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Table 1. Cont. 
Ensembl Gene ID  Gene Name  Description  Fold Change  FDR 
ENSG00000006327 TNFRSF12A  Fucosyltransferase  1  5.13  286.27 
ENSG00000184545  DUSP8*  Dual specificity phosphatase 8  5.05  87.30 
ENSG00000130766 SESN2  Sestrin  2  4.84 593.42 
ENSG00000070669 ASNS  Asparagine  synthetase  4.80  577.30 
ENSG00000136997 MYC  v-myc  myelocytomatosis viral oncogene homolog  4.71  991.67 
ENSG00000168679  SLC16A4  Solute carrier family 16 (monocarboxylic acid transporters), member 4  4.65  24.23 
ENSG00000099889  ARVCF  Armadillo repeat gene deletes in velocardiofacial syndrome   4.53  240.65 
ENSG00000162772 ATF3*  Activating  transcription  factor  3  4.47  695.61 
ENSG00000106948 AKNA  AT-hook  transcription  factor  4.45  773.28 
ENSG00000167861  C17orf28  Chromosome 17 open reading frame 28  4.43  142.87 
ENSG00000138685 FGF2  Fibroblast  growth  factor  2  4.08  23.78 
ENSG00000105327  BBC3  BCL2 binding component 3  4.06  230.60 
ENSG00000111087 GLI1  Glioma-associated  oncogene  homolog 1 (zinc finger protein)  4.02  41.66 
ENSG00000065911 MTHFD2  Methylenetetrahydrofolate  dehydrogenase (NADP+ dependent) 2,  4.00  693.07 
ENSG00000115520  COQ10B  Coenzyme Q10 homolog B (S. cerevisiae)  3.96  22.43 
ENSG00000105499  PLA2G4C*  Phospholipase A2, group IVC (cytosolic, calcium-independent)  3.92  44.14 
ENSG00000065600 TMEM206  Transmembrane  protein  206  3.90  57.11 
ENSG00000108551 RASD1  RAS,  dexamethasone-induced  1  3.89  70.16 
ENSG00000152137  HSPB8  Heat shock 22kDa protein 8  3.87  64.97 
ENSG00000112182  BACH2  BTB and CNC homology 1, basic leucine zipper transcription factor 2  3.83  76.67 
ENSG00000157765 SLC34A2 
Homo sapiens cDNA FLJ90534 fis, highly similar to Homo sapiens sodium 
dependent phosphate transporter isoform NaPi-3b mRNA 
3.80 41.45 
ENSG00000163393  SLC22A15  Solute carrier family 22 (organic cation transporter), member 15  3.77  104.50 
ENSG00000168003  SLC3A2  Solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2  3.77  1977.88 
ENSG00000164949  GEM  GTP binding protein overexpressed in skeletal muscle (GEM)  3.71  51.70 
ENSG00000107281  NPDC1  Neural proliferation, differentiation and control, 1  3.68  38.82 Viruses 2012, 4  
 
 
586 
Table 1. Cont. 
Ensembl Gene ID  Gene Name  Description  Fold Change  FDR 
ENSG00000154025  SLC5A10  Solute carrier family 5 (sodium/glucose cotransporter), member 10  3.67  50.35 
ENSG00000196517  SLC6A9  Solute carrier family 6 (neurotransmitter transporter, glycine), member 9  3.65  153.70 
ENSG00000166173  LARP6  La ribonuleoprotein domain family, member 6  3.62  146.96 
ENSG00000184371  CSF1  Colony stimulating factor 1 (macrophage)  3.58  132.33 
ENSG00000120129  DUSP1  Dual specificity phosphatase 1 (DUSP1)  3.53  446.22 
Table 2. The 25 most highly downregulated genes during acute HCV infection. Genes are presented in the order of fold change relative to 
controls and the time after HCV infection and FDR values are provided. Newly identified downregulated genes are shown in bold. A complete 
list of significantly upregulated genes are provided in Supplemental Materials. 
Ensembl Gene ID  Gene Name  Description  Fold Change  FDR  Time Point 
ENSG00000196475 GK2  Glycerol  kinase  2  −17.49  −22.37 72  h 
ENSG00000164588 HCN1 
Hyperpolarization activated cyclic nucleotide-gated potassium 
channel 1 
−15.64  −23.39 6  h 
ENSG00000101438 SLC32A1 
Solute carrier family 32 (GABA vesicular transporter),  
member 1 
−9.34  −68.18 72  h 
ENSG00000178695  KCTD12  Potassium channel tetramerisation domain containing 12  −8.10  −41.92 6  h 
ENSG00000182687 GALR2  Galanin  receptor  2  −6.23  −17.14 6  h 
ENSG00000120738 EGR1  Early  growth  response  1  −5.33  −259.33 6  h 
ENSG00000170989 EDG1 
Endothelial differentiation, sphingolipid G-protein-coupled 
receptor, 1 
−4.20  −21.82 72  h 
ENSG00000186074 NKIR  NK  inhibitory receptor precursor  −4.10  −17.18 72  h 
ENSG00000153266  ZNF312  Zinc finger protein 312  −3.91  −116.99 6  h 
ENSG00000143595 AQP10  Aquaporin  10  −3.32  −97.38 72  h 
ENSG00000153266  ZNF312  Zinc finger protein 312  −3.01  −71.64 72  h 
ENSG00000167183 PRR15L  Proline  rich  15-like  −2.95  −39.58 72  h 
ENSG00000131470  TBPIP  TBP-1 interacting protein (TBPIP)  −2.80  −17.88 6  h Viruses 2012, 4  
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Table 2. Cont. 
Ensembl Gene ID  Gene Name  Description  Fold Change  FDR  Time Point 
ENSG00000134389  CFHL5  Complement factor H-related 5  −2.72 0.37  48  h 
ENSG00000156475  PPP2R2B  Protein phosphatase 2, regulatory subunit B (PR 52)  −2.65  −26.85 72  h 
ENSG00000159261 CLDN14 Claudin  14  (CLDN14)  −2.58  −26.90 72  h 
ENSG00000186910 SERPINA11 
Serpin peptidase inhibitor, clade A  
(alpha-1 antiproteinase, antitrypsin) 
−2.53  −25.05 72  h 
ENSG00000182782  GPR109A  G protein-coupled receptor 109A  −2.50  −29.16 72  h 
ENSG00000182782  GPR109B  G protein-coupled receptor 109B  −2.50  −29.16 72  h 
ENSG00000197711 HP  Haptoglobin  −2.42  −291.19 72  h 
ENSG00000197711 HPR  Haptoglobin-related  protein  −2.42  −291.19 72  h 
ENSG00000130427 EPO  Erythropoietin  −2.39  −44.50 72  h 
ENSG00000143224 PPOX  Protoporphyrinogen  oxidase  −2.37  −15.81 6  h 
ENSG00000162344  FGF19  Fibroblast growth factor 19  −2.31  −40.79 6  h Viruses 2012, 4  
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The significantly differentially expressed genes in our RNA sequencing dataset were compared with 
a previously published comprehensive microarray dataset using a p value cutoff of <0.05 and fold 
change of 2 [9]. More than 80% of the differentially expressed genes at 48 and 72 hours in the RNA 
sequencing dataset were not significantly changed in the microarray analysis of poly(A) selected RNA 
of acutely HCV infected Huh 7.5 cells (Figure 2) [9]. Although minor differences in cell culture 
conditions might explain some of these differences, these results provide evidence that RNA 
sequencing analysis can provide new information regarding the changes in gene expression occurring 
during HCV infection.  
Figure 2. Significantly differentially expressed annotated genes as determined by RNA-seq 
analysis of 5' capped RNA compared to microarray analysis of poly(A)+ RNA (p > 0.05 
and fold change of 2.0, [9]) after 48 (Panel A) and 72 hours of HCV infection of Huh 7.5 
cells (Panel B).  
160 312  48  417  198 1182 
A    B   
RNA-seq  microarray   48 hours 
72 hours   
 
Approximately 37% of the genes that were significantly differentially expressed at 48 hours were 
also significantly changed at 72 hours. Highly differentially expressed transcripts that were newly 
identified or previously unvalidated were studied by qPCR analysis of six additional replicates of 
JFH-1 infected Huh 7.5 cells (Figures 3–7, and Figures S1 to S4).  
The gene with the highest fold change (20-fold increase) in expression 48 and 72 hours after HCV 
infection was fucosyltransferase 1 (FUT1) which is involved in protein fucosylation and cell signaling 
(Figure 3, Panel A). A 24-fold increase in FUT1 mRNA levels after 72 hours of infection was 
confirmed by qPCR analysis (Figure 3, Panel B). Previous microarray studies also showed 
upregulation of this transcript in HCV JFH1-J6 infected Huh 7.5 cells [9]. Significant increases in 
mRNA levels of glycosyltransferase genes involved in the synthesis of protein-bound and lipid-bound 
oligosaccharides were also identified, indicating that regulation of glycosylation pathways are affected 
by acute HCV infection (Supplemental Table 1). Since HCV envelope glycoproteins are modiﬁed by 
N-linked glycosylation, some of these gene products may be required for viral protein processing and 
regulation of their function. Viruses 2012, 4  
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Figure 3. Increased expression of fucosyltransferase 1 (FUT1, Chr 19, − strand) during 
acute HCV infection. (A) RNA sequencing analysis of acutely HCV infected cells showed 
a 20.5-fold increase in FUT1 gene expression with a highly significant FDR of 105 
(represents <0.0000000001 false positives out of 100). Gene expression is displayed as the 
number of 36nt sequencing reads per kilobase of gene length per million reads (RPKMI) 
using the Integrated Genome Browser (IGB) (Experimental Procedures). The y-axis 
represents RPKMI, and x-axis represents chromosome location and gene structure. To 
present a better view of gene exon structure, the IGB sliced view that minimizes the size of 
intronic regions was used. RNA sequencing reads from a pool of three replicates of HCV 
infected cells at 6, 48 and 72 h are shown in red and mock-infected cells in blue. Gene 
structure (in kilobases), orientation and chromosomal location (gene start provided in 
parenthesis) are shown in the lower part of the panel next to Ref Seq. (B) Quantitative PCR 
(qPCR), although it measures only one specific region of transcript expression unlike 
sequencing analysis, was used to validate the RNA-seq results. Six mock infected and six 
HCV infected Huh 7.5 cell cultures (9.6 cm
2) were analyzed by qPCR (n = 3 for each 
culture, total of n = 18) at each time point. qPCR analysis showed a 24.8-fold increase in 
mRNA at 72 hours after HCV infection. The qRT-PCR data represent the mean ± SEM and 
the location of qPCR primers is indicated in the IGB schematic in Panel A. p-values were 
calculated using the Student's t-test, and p values <0.05 were considered significant. 
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The Kelch domain containing 7B (KLHDC7B) gene, encodes a protein of unknown function that 
contains Kelch-repeat β-propellers that are known to undergo a variety of binding interactions with 
other proteins [21]. KLHDC7B was upregulated 19-fold in acutely HCV infected cells compared to 
controls (Figure 4, Panel A). Upregulation of this gene during acute HCV infection was not reported in 
previous studies [8,9,22]. The RNA-seq finding was confirmed by qPCR analysis with a fold change 
of 9 after 72 hours of infection (Figure 4, Panel B).  
Figure 4. Increased expression of the Kelch domain containing 7B (KLHDC7B, Chr 22, + 
strand) gene during acute HCV infection. (A) The RNA-seq analysis identified an 18.9-fold 
increase KLHDC7B mRNA with an FDR value of 141.9. The gene structure, orientation 
and chromosomal location are shown below the sequencing reads. This example shows one 
benefit of analyzing 5' capped by RNA sequencing and provides evidence that an isoform 
of KLHDC7B mRNA with a longer 5' untranslated region (UTR) is expressed in Huh 7.5 
cells after infection with HCV. There was no annotated gene or EST on the minus strand in 
this genomic region that provided an alternative explanation for the sequence reads 
observed upstream of the KLHDC7B 5' end. (B) qPCR analysis verified a major increase in 
expression of KLHDC7B and showed a 9-fold increase mRNA with the PCR primers used. 
 Viruses 2012, 4  
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Indicating a major reprogramming of host cell gene expression, a total of 276 genes involved in 
gene transcription were differentially expressed by 72 hours of acute HCV infection. Eighty percent of 
these genes were not previously determined differentially regulated during acute HCV infection. This 
included the upregulation of transcription factors regulating cell differentiation, inflammation and 
signal transduction including krupple-like factor 4 (KLF4, 15-fold), hexokinase domain containing 1 
(HKDC1, 15-fold), ankyrin repeat domain 1 (ANKRD1, 12-fold), v-myc myelocytomatosis viral 
oncogene (MYC, 5-fold), and AT-hook transcription factor (AKNA, 4-fold) (Table 1). The upregulation 
of AKNA, MYC, and ANKRD1 mRNA transcripts was confirmed by qPCR (Figure 5 and Supplemental 
Figures 1 and 2, respectively). Two of these genes, not reported to be upregulated in previous studies, 
were KLF4 and AKNA. The AT-hook transcription factors, of which AKNA is a member, repress or 
activate gene networks controlling inflammation, development, carcinogenesis, and metabolism are 
thought be critical in some disease states [23,24]. The finding of upregulation of AKNA expression 
raises the question that either the host or virus uses this change to downregulate a network of 
inflammatory genes during acute HCV infection. 
Figure 5. Increased expression of AT-hook transcription factor (AKNA, Chr 9, − strand) 
during acute HCV infection. (A) RNA sequencing analysis showed a 4.5-fold increase with 
an FDR of 773.3 and (B) qPCR showed a 4.3-fold increase in AKNA mRNA at 72hr after 
HCV infection.  
 Viruses 2012, 4  
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Our RNA sequencing analysis identified another biologically unpredicted pair of genes that were 
activated during acute HCV infection. Inhibin beta isoforms A and E (INHBA and INHBE) were 
upregulated 14 and 6-fold after acute HCV infection (Table 1, Figure 6). Upregulation of INHBE was 
confirmed increased by qPCR analysis with an average fold change of 7 (Figure 6, Panel B). Inhibin 
beta E (INHBE) is a member of the transforming growth factor (TGF-β) super family and plays a role 
in cell growth and proliferation [25]. INHBE is involved in regulation of human reproductive 
hormones and is dysregulated in endometrial and cervical carcinoma [25,26]. The upregulation of 
INHBE suggests that nonclassical TGF-β family member genes play regulatory roles during acute 
HCV infection.  
Figure 6. Increased expression of inhibin beta E (INHBE, Chr 12, + strand) during acute 
HCV infection. The RNA sequencing (6.4 fold increase, FDR = 1324.3) (A) and qPCR 
results (B) are presented as in Figure 3. 
 
 
A number of studies have demonstrated the formation of membranous webs that include HCV 
replication complex proteins, during HCV infection [27,28]. Our RNA sequencing analysis revealed 
a  6-fold increase in filamin C (FLNC) mRNA, which produces a gene product that is critical in   
cross-linking actin filaments and attaching membrane glycoproteins proteins to the actin cytoskeleton 
(Supplemental Figure 3). Although increased FLNC was previously reported, we identified 128 
additional members of the cytoskeleton gene family that were significantly differentially expressed 
during acute HCV infection. Ninety-six of these genes were not previously identified, including 
upregulation of APS, SLC1A4, PSEN2, MAP1B, and PXK (Supplemental Table 1). This data supports Viruses 2012, 4  
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the previously reported role of actin and tubulin in formation of HCV replication complexes and RNA 
synthesis [27].  
RNA sequencing analysis also demonstrated a 6.8-fold upregulation (FDR of 202.4) of alpha-kinase 
3 gene (ALPK3), a gene that may connect HCV RNA to the cytoskeleton, during acute HCV infection 
that was not previously reported. qPCR analysis confirmed upregulation of ALPK3 with a 4-fold 
increase (Figure 7). ALPK3 contains shares protein domains with TRAF3IP1 (or MIP-T3) that binds 
microtubules, TRAF3 and associates with the HCV IRES in a riboproteomics study [29,30]. This 
suggests a possible mechanism for connecting HCV RNA to the cytoskeleton for regulatory purposes, 
such as replication complex formation [29,30].  
Figure 7. Increased expression of Alpha-kinase 3 (ALPK3, chr 15, + strand) during acute 
HCV infection. RNA sequencing analysis of acutely infected Huh 7.5 cells showed a 6.8 
fold increase ALPK3 mRNA with a highly significant FDR value of 202.4. (A) and qPCR 
analysis verified a significant increase (B). 
 
2.3. Changes in Kegg Pathways during Acute HCV Infection 
The RNA sequencing database of differentially expressed genes was analyzed to determine which 
of the 228 KEGG pathways were significantly enriched (altered) during acute HCV infection. MAPK 
signaling was the only KEGG pathway enriched at all times examined and had a progressive increase 
in the number of genes activated from 6 to 72 hours (Table 3). Other KEGG pathways enriched at both 
48 and 72 hours post infection were adipocytokine signaling and TGFβ signaling. The TGFβ signaling Viruses 2012, 4  
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pathway was previously reported to be deregulated during acute HCV infection and regulates cell 
cycle arrest, apoptosis, and fibrosis under experimental conditions [9]. The majority of enriched 
KEGG pathways were observed at 72 hours after infection. Although this included pathways reported 
in previous studies, such as apoptosis, sphingolipid metabolism and amino acid metabolism, there were 
a number of biologically relevant enriched pathways that we found in this analysis [8,9]. Novel KEGG 
pathways enriched at 72 hours included Insulin signaling pathway, RIG-I like receptor signaling, 
H. pylori pathway cytosoloic-DNA sensing pathway, extracellular matrix (EMC)-receptor pathway, 
NOD-like receptor signaling and Notch signaling. Significant alterations in RIG-I signaling gene 
expression were surprising since Huh 7.5 cells have a mutant RIG-I gene that impairs the interferon 
response. Some of the genes in this pathway may partly compensate for this RIG-I mutation.  
Table 3. Enriched Kegg pathways during acute HCV infection. Differentially expressed 
genes (DEGs) at each time point were analyzed with software that utilizes a Fisher’s exact 
test (p < 0.05 considered significant) to determine enriched pathways. The background 
gene list included only genes that were expressed (EGs), while genes that were not 
expressed were excluded from statistical analysis.  
KEGG Pathway name  Genes in 
Pathway 
6 h  48 h  72 h 
DEGs 
(EGs)  p value  DEGs 
(EGs)  p value  DEGs 
(EGs)  p value 
MAPK signaling  268  5 (168)  0.003  13 (173)  0.01  33 (177)  0.0005 
Cytokine-cytokine receptor interaction  265     9  (90)  0.005  19  (92)  0.002 
Antigen processing and presentation  78  2  (36)  0.02      
RIG-I-like receptor signaling  71      12  (44)  0.001 
Toll-like receptor signaling   102       11  (58)  0.03 
NOD-like receptor signaling  59  9  (40)  0.02
Cytosolic DNA-sensing pathway  56      7  (28)  0.02 
Epithelial cell signaling in H. pylori 
infection  68      11  (53)  0.01 
Adipocytokine signaling  68    7  (50)  0.002  13  (48)  0.0008 
TGF-beta signaling  85      6  (68)  0.03 13  (55) 0.02 
Regulation of autophagy  34      5  (18)  0.03 
Apoptosis  89      12  (68)  0.04 
ECM-receptor interaction  85    4  (37)  0.04    
Jak-STAT signaling  155       15  (77)  0.01 
Hepatitis C  135       20  (98)  0.002 
mTOR signaling  52  2  (41)  0.02      
Hedgehog signaling  56    5  (30)  0.004    
Notch signaling  47    9  (37)  0.01 
Renal cell carcinoma  70  2  (58)  0.04      
Basal cell carcinoma  55    4  (31)  0.02    
Hematopoietic cell lineage  88    4  (29)  0.02    
Osteoclast differentiation  128     7  (76)  0.02  19  (76)  0.0001 
Insulin signaling  138       19  (110)  0.01 
Type II diabetes mellitus  48    4  (27)  0.01    
Aminoacyl tRNA biosynthesis  63      13  (41)  0.0001 
Ribosome biogenesis in eukaryotes  81      12  (44)  0.001 
Sphingolipid metabolism  40      9  (33)  0.005 
Glutathione metabolism  50  2  (39)  0.03      
Cyanoamino acid metabolism  7  1  (4)  0.02      Viruses 2012, 4  
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Table 3. Cont. 
KEGG Pathway name  Genes in 
Pathway 
6 h  48 h  72 h 
DEGs 
(EGs)  p value  DEGs 
(EGs)  p value  DEGs 
(EGs)  p value 
Ubiquinone and other terpenoid-
quinone biosynthesis  7  1  (5)  0.03      
Taurine and hypotaurine metabolism  10  1  (5)  0.03      
Neurotophin signaling  127       18  (94)  0.006 
One carbon pool by folate  18      5  (17)  0.03 
Prion diseases  36 2 (21) 0.006    
2.4. RNA Sequencing Analysis of 5' Capped RNA Identifies Upregulated Unannotated Pol II 
Transcripts 
Using the open source software program Cufflinks we identified more than 1500 unannotated 
transcriptionally active regions in HCV infected Huh 7.5 cells that produced 5' capped RNA (data not 
shown) [31]. These regions were a minimum of 2 kilobases from well annotated genes in the Ensembl 
62 (Hg19) database. Some of these transcripts may represent alternative 5' start sites or alternative 
3' poly(A) sites of annotated genes. We further refined this list of unannotated transcripts to focus on 
RNAs that were differentially expressed in HCV infected compared to control cells after 48 and 
72 hours of infection with an FDR of ≥13 and a fold change of 1.5. We also used an RPKM (reads per 
kilobase of gene exon length per million reads) cutoff of 5 to identify novel RNAs that were 
moderately to highly expressed (Table 4).  
Table 4. Unannotated transcripts increased during acute HCV infection. It displays ten 
unannotated transcripts with their respective chromosome location, transcript size, fold 
change and FDR. RPKM = reads per kilobase per million reads. 
GENOME POSITION 
Chr Start  Stop 
Total 
BPs 
HCV 
RPKM 
MOCK 
RPKM 
Fold 
Change 
FDR 
Time 
point 
8  47528429 47529270  841  7.74 0.93 7.52 113.0  72  h 
5  85865845 85866626  781  10.08  3.37 2.92 57.2  72  h 
4  1384494  1385183  689  6.10 2.27 2.59 21.4  72  h 
8  87354779 87355196  417  7.95 3.04 2.50 14.7  72  h 
16  31580193 31580636  443  10.55  4.19 2.44 21.4  72  h 
17  7967452 7968557  1105  6.15  2.62  2.33  101.1  48  h 
16  21513065 21513758  693  8.71 3.94 2.17 21.9  72  h 
15  64995200 64995463  263  31.29  15.07 2.07 95.1  48  h 
11  122489643  122489913  270  9.48 4.76 1.97 18.1  48  h 
14  65747331 65747885  554  11.64  6.17 1.86 15.4  72  h 
 
One of the unannotated Pol II transcripts was upregulated by 5.0-fold at 48 and 7.5-fold at 72 hours 
after HCV infection and originated from a 39 kilobase region on chromosome 8 (Figure 8, panel A). 
qPCR analysis was performed on six additional replicates of HCV and mock infected cell cultures and 
showed a 2.5-fold increase in this RNA (p-value < 0.05) at the 72 hours (Figure 8, panel B). Viruses 2012, 4  
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Figure 8. Differential expression of a novel Pol II transcript during acute HCV infection. 
(A) RNA sequencing analysis of 5' capped RNA showed a 7.5-fold increase in an 
unannotated RNA with a highly significant FDR of 113. The RNA transcript predicted by 
nscan is shown in lower part of Panel A in green [32]. (B) qPCR analysis showed   
a 2.5-fold increase in this unannotated Pol II RNA during acute HCV infection. The data 
are presented as in Figure 3.  
 
 
Further bioinformatic analysis of this chromosome 8 region revealed that it has sequence homology 
to the recently identified asparagine synthetase pseudogene 1 (ASNSP1). We performed 5' and 3' rapid 
amplification of cDNA ends (RACE) to further characterize this Pol II RNA. The analysis showed that 
the Pol II RNA originating from chromosome 8 contains multiple splice variants with the largest 
variant extending beyond the boundaries of the recently identified pseudogene. Using the ORF Finder 
software (Softberry) we found a small peptide of 48 amino acids encoded in this unannotated 
transcript [33]. RACE sequence data confirmed that the novel RNAs were indeed originating from 
chromosome 8 and not from the parent gene on chromosome 7. We are not aware of other reports of 
pseudogenes exhibiting increased expression during acute HCV infection. 
2.4. Effect of Gene Silencing of Selected Upregulated Genes on HCV JFH-1 Replication and Infectious 
Virus Production 
The significant upregulation of at least 18 host genes involved in glycoprotein production and 
processing, such as FUT1 (20–25-fold increased), was noted and raised the questions about the role of 
this pathway in the HCV life cycle (Supplemental Table 1). Fucosylation of viral proteins, such as Viruses 2012, 4  
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influenza hemagglutinin, or cellular glycoproteins involved in Golgi-dependent processes as viral 
secretion, might be essential to HCV replication and the production of mature infectious virions 
[34,35]. Since the mRNA of the FUT1 gene was so markedly upregulated, we determined if silencing 
of  FUT1 would alter HCV replication in the infectious cell culture system. In addition, since 
KLHDC7B was also highly upregulated during acute HCV infection (19-fold by RNA-seq) we also 
determined the effect of silencing this gene prior to HCV infection in Huh 7.5 cell cultures. 
FUT1 and KLHDC7B mRNA levels were downregulated by specific siRNAs as verified by qPCR 
analysis. FUT1 mRNA was 46%, 35% and 26% of controls (cells transfected with scrambled siRNAs), 
and  KLHDC7B mRNA level was 43%, 39% and 24% at 24, 48 and 72 hours after transfection, 
respectively (Figure 5S, Panel A). Control siRNAs did not downregulate FUT1 or KLHDC7B and had 
no significant cell toxicity (Figure 5S, Panel B). 
24 hours after siRNA transfection, cells were infected with JFH-1 (MOI = 0.5). The effect of 
siRNA gene silencing on HCV replication was first measured by qPCR quantification of HCV RNA as 
described in Experimental procedures. HCV RNA levels were reduced by 50%, 77% and 80% in 
FUT1 and by 74%, 77% and 78% in KLHDC7B gene siRNA treated cells, relative to controls, at 24, 
48 and 72 hours after HCV infection, respectively (Figure 9, Panel A).  
The effect of siRNA gene silencing of FUT1 and KLHDC7B on the production of infectious HCV 
particles in cell culture was also determined. Media collected from siRNA treated and HCV RNA 
transfected cells, plus controls, was assayed to determine the titer of infectious virus produced in each 
culture. The titer of infectious HCV produced in cell cultures with FUT1 silenced was decreased by 
27%, 50% and 50% at 24, 48 and 72 hours after HCV infection, respectively (Figure 9, Panel B). 
Silencing of KLHDC7B decreased the titer of infectious HCV produced in cell culture by 72%, 76%, 
and 66% at the designated times relative to controls (Figure 9, Panel B).  
3. Discussion 
We describe the first report of RNA sequencing analysis of 5' capped RNAs isolated from acutely 
HCV infected Huh 7.5 cells and provide evidence that this approach identifies many new annotated 
and unannotated genes that are differentially expressed during acute HCV infection. At 48 and 72 hours 
post infection more than 80% of significantly differentially expressed genes reported in our study were 
not identified in prior gene array analysis of acute HCV infection using the same fold change. We also 
present the first analysis of unannotated transcripts, some likely to be ncRNAs, that are differentially 
expressed during acute HCV infection and may play significant roles in the viral-host interactions. 
Follow up siRNA studies of two newly identified, highly upregulated genes, FUT1 and KLHDC7B, 
provided evidence their expression during acute HCV infection is essential for the production of HCV 
RNA and infectious viral particles. Our results suggest that this general approach will have 
applications in studying viral-host interactions in both model systems and clinical biospecimens. Our 
studies were done in proliferative, standard cultures, of Huh 7.5 cells. It will be of interest to determine 
the similarities and differences in gene expression of acutely HCV infected proliferative and growth 
arrested differentiated human hepatoma-derived cells [36]. In comparison with our reported ENCODE 
tilling array (interrogates 1% of the human genome) analysis of HCV infected cirrhotic liver that 
identified 95 differentially expressed genes as compared to controls, our current analysis of acutely Viruses 2012, 4  
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infected hepatoma cells showed that 20% of these genes were also differentially expressed [14]. This is 
a relatively large percentage of overlap since liver represents a much more complex transcriptome due 
to the presences of a number of other cell types besides hepatocytes and the fact that the ENCODE 
analysis was of chronically infected cirrhotic liver. Similar changes in genes involved in the immune 
response (e.g., IRF1, RFX5 and PSMB4), cell structure (FLNA, PLXNA3 and CAPZA) and growth 
(CTGF and RHBDF1) were observed in the prior and current studies, providing evidence that there is 
overlap in the host response to acute and chronic HCV infection and that the Huh 7.5 model can partly 
mimic in vivo processes occurring during HCV infection. The results also indicate that transcriptome 
changes in acutely infected Huh 7.5 cells become more profound with propagation of infection. This 
suggests that as a greater percentage of cells becomes infected that the biological effects become more 
pronounced, raising interesting questions regarding the pathobiology in selected patients with hepatitis C. 
Figure 9. siRNA silencing of FUT1 and KLHDC7B inhibit HCV replication and infectious 
virus production. Huh 7.5 cells were transfected with control siRNA (white bars), FUT1 
(gray bars) or KLHDC7B (black bars) and infected with JFH-1 (MOI = 0.5) for two hours, 
supplemented with fresh complete DMEM and continuously cultured to 24, 48, and 
72 hours. At each time point, HCV RNA was measured by real-time PCR (A) and the titer 
of infectious HCV was measured by serial dilution of culture supernatants (B). The percent 
inhibition produced by each siRNA is shown above each bar in the graph. 
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3.1. Acute HCV Infection Reprograms Gene Transcription of Infected Cells 
Many genes regulating transcription, representing approximately 20% of all genes differentially 
expressed at 72 h, showed major changes in expression during acute HCV infection. Although changes 
in interferon stimulated and other genes during HCV infection, activated initially via PAMP (pathogen 
associated molecular patterns) pathways such as RIG-I and Toll-like receptors, have been well 
described during HCV infection this study identifies additional gene networks that are stimulated or 
inhibited during acute infection. This included a dramatic 10–20 fold increase in KLF4 and ANKRD1 
mRNA and a 4-fold increase in AKNA, mRNA indicating that the gene networks they regulate undergo 
major changes during acute HCV infection.  
A number of members of the Sp1-like/KLF family of transcription factors (SP1,  SP5,  KLF10, 
KLF11, KLF13, KLF15, KLF16, KLF3, KLF6, KLF9) were significantly upregulated during acute 
HCV infection. They regulate the biological processes of cell growth and morphogenesis [37]. KLF4 
was previously shown to play a crucial role in early development by regulating cell differentiation, 
tumor suppression, and steam cells [37,38]. Although changes in KLF4 expression has not been 
reported during acute HCV infection, it has been found to be upregulated in macrophages infected with 
Sendai virus, bronchial epithelial cells infected with RSV, and in endothelial cells exposed to Candida 
albicans blastospores [39–41].  
AKNA is predominantly expressed by lymphoid tissues and encodes a protein that binds to DNA by 
a conserved nine amino acid domain called AT-hook, which has been implicated in regulating gene 
transcription by altering chromatin structure. Studies have provided evidence that AKNA plays a 
critical role in regulating immune responses by activating the expression of the CD40 receptor and its 
ligand CD40L/CD154, two lymphocyte cell surface molecules critical for antigen-dependent-B-cell 
development [42]. Recent studies showed that AKNA is a major modulator of the intensity of in vivo 
inflammatory responses [23]. Knocking out AKNA sensitizes mice to pathogen-induced inflammation 
and caused sudden neonatal death due to systemic inflammation, especially in the lung, induced by 
inflammatory cytokines (interferon-1β, interferon-1γ) and proteins (neutrophilic granule protein, 
cathelin-related antimicrobial peptide) [23]. AKNA has not been previously reported to be differentially 
regulated during viral infections. Our observation suggests that the AKNA regulated gene network 
suppresses the innate response during acute HCV infection and deserves follow up studies.  
In addition to genes regulating transcriptional and translational processes, genes involved in RNA 
catabolism, both promoting (such as UPF1,  UPF3B and SMG1) and inhibiting RNA degradation 
(RNH, GSTP1 and TNKS1BP) were significantly upregulated during acute HCV infection. To establish 
and maintain infection, RNA viruses must escape the host cell RNA decay machinery [43]. Some of 
the genes showing significant increases in mRNA during acute HCV infection (such as HuR, PCBP2) 
encode proteins that were reported as critical in protecting Sindbis and Polio viruses from host cell 
driven RNA decay [44,45]. Genes involved in stabilizing cellular mRNAs, such as PCBP4 (poly(rC) 
binding protein 4) and PCBP1, were also significantly upregulated. Previous reports have shown 
PCBP2 is hijacked by viruses (such as polio, coxsackie and hepatitis A virus) and used to promote 
optimal viral translation and gene expression [46–49]. In addition, PCBP2 and PCBP isoforms are also 
found in stress granules and play a role in 3' end mRNA processing [48,49]. Other differentially 
expressed genes that are part of RNA decay pathways that were not previously known to be altered Viruses 2012, 4  
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during HCV infection were identified. They include HNRPU (2.2-fold increase; participate in   
VSV-mediated shutoff of host RNA metabolism [47]), RNH1 (2-fold increase; RNA decay regulation), 
UPF3B (2-fold increase; nonsense mediated mRNA decay), DCP2 (1.6-fold increase;   
mRNA-decapping), XRN2 (1.6-fold increase; 5'-3' exonuclease), RNASEH1 (1.6-fold increase; mRNA 
decay), PABPC1 and PABPC3 (both 1.5-fold increase; involved in mRNA deadenylation) [43,50].  
ALPK3, upregulated by 4 to 7-fold our analysis and not previously reported, is a member of a 
unique family of atypical protein kinases implicated in regulating a number of cellular processes 
including mRNA translation [51]. Upregulation of ALPK3 has been described in acute infection of 
dendritic cells during with measles virus [52]. The protein encoded by ALPK3 contains at least three 
protein domains [53]: an alpha-kinase domain at the C-terminus, imunoglobulin domain and 
immunoglobulin I-set domain. It also shares a microtubule interacting protein domain that associates 
with TNF receptor-associated factor 3 (TRAF3), and is found in TRAF3IP1 (or MIPT3) [29]. TRAF3 
is an ubiquitin ligase and plays a critical role in activation of the innate immune response by regulating 
signal transduction from pathogen recognition receptors [23]. A recent study showed that MIP-T3 is a 
negative regulator of the type I IFN response by activators including RIG-I, MDA5 and TLR3 [54]. 
Moreover, MIP-T3 expression suppresses the activation of IFN-stimulated response elements in a 
dose-dependent manner [54]. Since HCV is known to impair the host innate immune response, ALPK3 
upregulation may represent an additional viral mechanism for impairing host innate immunity and 
facilitating chronic HCV infection. The increase in ALPK3 may also facilitate 5' cap-independent HCV 
RNA translation or replication. A protein domain shared by alpha protein kinase-3 (ALPK-3) and  
MIP-T3 was found in a RNP complex with the HCV IRES [30]. One possibility is that ALPK-3 could 
join the HCV RNA in replication complexes to the cytoskeleton and membranous webs [28].  
3.2. Acute HCV Infection Related Kegg Pathways 
RNA sequencing analysis identified several host response pathways, including adipocytokine 
signaling, insulin signaling, and RIG-I signaling, that were not identified in prior analysis of acutely 
HCV infected Huh 7.5 cells [9,10]. TGF-beta signaling was activated, as in gene array studies of acute 
HCV infection, which has been implicated in pathological effects of chronic infection [9,22].  
More than ten genes associated with RIG-I signaling were increased during acute HCV infection in 
our analysis. This was surprising in view of the mutation in RIG-I in Huh 7.5 cells that ablates RIG-I 
signaling [55]. The upregulation of multiple genes downstream from IPS-1 ( G1P2, 3.4-fold; IL8,  
2.9-fold; TRAF3, 1.9-fold, and TRAF2, 1.9-fold) suggests crosstalk between other molecular pathogen 
recognition receptors and the RIG-I pathway in Huh 7.5 cells.  
Previous reports provide evidence that HCV perturbs glucose metabolism, leading to insulin 
resistance that accelerates liver fibrogenesis, impairs the response to interferon treatment and increases 
the risk of HCC [56]. Our analysis found additional genes upregulated during acute HCV infection, not 
previously identified, such as HKDC1 (14.7-fold), IRS2 (2.9-fold), RHOQ (2.2-fold), SKIP, (1.9-fold), 
IRS1 (1.6-fold) and insulin receptor substrate-2 (IRS2), the main effector of insulin signaling in the 
liver [57] (Supplemental Figure 4). Since IRS-2 is involved in activation of lipogenic genes, it may 
play a role in the formation of lipid droplets on which HCV replication complexes assemble [58,59]. Viruses 2012, 4  
 
 
601
IRS2 overexpression has also been reported in the early phase of murine liver tumorigenesis and in 
human HCC pathological specimens and HCC lines [59].  
Approximately 200 genes were found to be differentially expressed by RNA-seq analysis are 
involved in embryonic development and more than seventy percent of them were not previously 
reported to be differentially expressed during acute HCV infection. They include FGF2 and FZD9 
(both 4-fold increase), CEBPB (2.7-fold increase), LNK, MAFG and TFEB (all 2.5-fold increase), 
PKD1 and CELSR1 (both 2.3-fold increase), JAG2 and NOTCH1 (both 2.1-fold increase). We provide 
the first evidence that the Hedgehog and Notch signaling pathways are increased during acute HCV 
infection. The Hedgehog pathway is a critical regulator of embryonic development, is increased in 
chronic HCV and HBV hepatitis, and plays a key role in fibrogenesis and the development of HCC 
[60–62]. A recent study provides evidence that Hedgehog signaling also plays a role in creating an 
environment supportive of HCV replication in cell culture [63]. These results provide evidence for the 
Hedgehog signaling pathway playing a role in during the establishment of HCV infection and its long 
term pathological effects during chronic infection. 
3.3. HCV and Cellular Glycosylation Pathways 
A number of host genes involved in protein glycosylation were significantly increased and not 
previously reported to be changed during acute HCV infection. In particular, a dramatic 21 to 25-fold 
increase in fucosyltransferase 1 mRNA was observed at 72 hours after infection. Although, an increase 
in FUT1 expression has been reported in previous studies its effect on HCV replication remained 
unknown.  FUT1 has been noted to be upregulated, most likely by a viral induced transcriptional 
change, during acute CMV infection and was suggested to play a role in virus spreading among cells 
or possibly viral escape from immune responses [64]. In this study we show that silencing FUT1 in 
Huh 7.5 cells inhibited HCV RNA replication by up to 80% of controls and infectious virion 
production was inhibited by 50%. These results provide direct evidence that the dramatic induction of 
FUT1 does have a biological role during acute HCV infection and encourage follow up studies 
regarding the mechanism of this FUT1 induction and its function during acute infection.  
In addition to a role in early viral replication, changes in protein glycosylation also play an 
important role in the pathogenesis and progression of some liver diseases [65,66]. Altered 
glycosylation is recognized as a core characteristic of many cancer cells and changes in glycan 
structures have been used in the development of biomarkers for liver damage [65,66]. Fucosylation is 
one of the most important glycosylation events in cancer cells; this pathway includes eleven known 
fucosyltransferases, as well as GDP-fucose synthetic enzymes and a GDP-fucose transporter [67]. Our 
study revealed increased expression of the FUT1 (21 to 25-fold) (α1,2 fucosyltransferases), FUT5  
(5-fold) (α1,3/α1,4), and FUT8 (2-fold) (α1,6 or core fucose). In addition, genes involved in de novo 
GDP-fucose synthesis pathway as well as a salvage pathway showed increased expression (FUK and 
TSTA3) at 48 hours. Well-known fucosyltransferase products are sialyl selectin receptors (Lewis 
glycol-epitopes) that play a critical role in leukocyte extravasation, lymphocyte maturation, and cell 
signaling and development [67]. HIV, CMV, VZV and HSV-1 infections induce expression of Lewis 
X and Lewis Y epitopes by activating transcription of FUT genes, which play a vital role in the spread 
of these viruses [64,68]. A similar strategy of hijacking the selectin-dependent mechanism (binding of Viruses 2012, 4  
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sLeX on tumor cells to P-selectin on endothelial cells) was reported during metastasis of several 
tumors [69]. Recent studies provide evidence that HSV-1 induction of specific FUTs (FUT3, FUT5, 
and  FUT6) was initiated by interactions between viral dsRNA and PKR and RIG-I. It was also 
reported that the herpesviruses induced increases in Lewis antigens and the sialylation of other 
glycoproteins (CD45) regulate TCR signaling, adhesion and apoptosis in thymocytes [70–72].  
3.4. KLDC7B Gene Silencing Inhibits HCV Replication 
Regarding KLHDC7B, not normally expressed in human liver cells, one of our new findings was 
that it was highly upregulated (9 to 19-fold) during acute HCV infection. Moreover, siRNA silencing 
of KLHDC7B in cell cultures inhibited HCV RNA replication and the production of infectious virus. 
KLHDC7B contains six kelch motifs that are found in a number of proteins, some with roles during 
other infectious conditions [21]. Proteins with kelch-repeat domains bind other proteins, notably actin 
filaments [21]. 
Mining the GEO database [73] we found that KLHDC7B mRNA was increased under a number of 
biological conditions with most of them due to infectious agents. KLHDC7B was upregulated during 
vulvar intraepithelial neoplasia due to human papillomaviruses [74] and in dendritic cells infected with 
Chlamydia pneumonia [75]. A role for KLHDC7B during acute infections is further suggested by its 
upregulation in dendritic cells infected with Aspergillus fumigatus [76] and bronchial epithelial cells 
during acute RSV infection [77]. KLHDC7B expression is also induced by interferon gamma, TNF-α 
and IL-4 [78]. Although the function of KLHDC7B remains unknown, our results provide the first 
evidence that changes in KLHDC7B expression have significant effects on acute HCV infection. In 
view of the proposed role of KLHDC7B in actin binding [79], we speculate that it has a role in 
cytoskeleton and membrane rearrangements required for efficient HCV RNA replication and possibly 
secretion of infectious virus. The specific function of increases in KLHDC7B during acute HCV 
infection will require further investigation.  
4. Experimental Procedures 
4.1. Cell Culture 
The human hepatoma cell line, Huh 7.5, was generously provided by Charles M. Rice and was 
maintained in Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen) supplemented with 
100 U/mL of penicillin, 100 µg/mL of streptomycin, nonessential
 amino acids, and 10% fetal bovine 
serum (FBS) (Invitrogen) at 37 °C in 5% CO2 [80].  
4.2. Production of Infectious HCV  
Hepatitis C virus was generated from construct HCV pJFH1 that was kindly provided by Wakita [81]. 
In vitro transcribed HCV JFH1 RNA was electroporated into Huh 7.5 cells and the transfected Huh 7.5 
cells were maintained and sub-cultured every three days. The titer of infectious HCV was determined 
by immunofluorescence assays with anti-NS5A antibody [82]. The viral titer is expressed as   
focus-forming units per
 milliliter (ffu/mL). Once the viral titer reached to 8.0 × 10
4 ffu/mL, the 
medium containing Hepatitis C virus was stocked at −80 °C as a stock.  Viruses 2012, 4  
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4.3. Infection of Cells with HCV JFH1  
Huh 7.5 cells were seeded at 2.5 × 10
5/well in 6-well plates (9.6 cm
2 per well). After 18 hours of 
culture, the cells were infected with HCV at an MOI of 0.5. The inoculums
 were incubated with cells 
for two hours at 37 °C and then supplemented
 with fresh complete DMEM. The cells were then 
continuously cultured to 6, 48, and 72 hours. Controls were Huh 7.5 cells grown under identical 
conditions and mock infected (conditioned media) for the same time. These time points were selected 
based on previous microarray studies showing maximal changes in differential gene expression after 
48 and 72 hours of acute JFH1 HCV infection [8,9]. The six hour time point was chosen as an interval 
when few gene expression differences would be observed between HCV and mock-infected cells.  
4.4. RNA Isolation  
Total RNA was purified from infected and mock-infected Huh 7.5 cells using Trizol (Invitrogen, 
Grand Island, NY, USA) as described previously [14]. RNA quality was assessed using a Bioanalyzer 
(Agilent, Santa Clara, CA, USA) and all samples had a minimum RIN of 9.0. Equal amounts of total 
RNA were pooled from three cultures (9.6 cm
2) for each condition and time point and 5' capped RNA 
was purified using a recombinant GST fusion high-affinity variant of eIF4E (eIF4EK119A) which binds 
m
7Gpp with a ten-fold higher affinity compared to wild-type eIF4E [12,17,83]. Six additional cultures 
(9.6 cm
2) for each condition and time point were used to isolate total RNA for qPCR validation 
studies. The quantity of all RNA samples was measured by NanoDrop analysis and its integrity 
confirmed with a Bioanalyzer. 
4.5. RNA Sequencing 
cDNA libraries were prepared from the 5' capped RNA samples using random hexamers following 
the Illumina RNA sequencing protocol [16]. Single 36bp RNA-Seq reads were obtained as previously 
described (Illumina GA II) [16]. A total of 17.2–17.6, 32.8–36.6 and 10.2–16.9 million sequencing 
reads were obtained for the 6, 48 and 72 hour HCV infected and control samples, respectively. 
Bioinformatic analysis of the sequencing data included adjustments for the depth of sequencing at 
different times (see below).  
4.6. Bioinformatics 
RNA sequencing reads were aligned to the February 2009 human reference sequence genome 
(GRCh37/hg19) using the Bowtie short read aligner [84]. Visualization tracks were prepared for each 
of the samples using the USeq ReadCoverage application; these tracks can be viewed using the 
Integrated Genome Browser (IGB) [85].  
Analysis to identify differential expression of genes began with the Ensembl list of known genes. 
The USeq DefinedRegionScanSeqs (DRSS) application was used to count the reads intersecting exons 
of each annotated gene and score them for differential expression in both infected and mock-infected 
cells [86]. These scores are controlled for multiple testing and ranked by false discovery rate (FDR) 
and normalized ratio. The criteria for designating individual genes as significantly differentially 
expressed was set at a transformed false discovery rate (designated FDR) of >13 (represents an Viruses 2012, 4  
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untransformed FDR <0.05 or <5 false positives per 100 observations) and normalized change of ≥1.5 
fold relative to controls [14]. Note: an FDR of 20 represents an untransformed FDR of 0.01 or 1 false 
positive per 100 observations and an FDR of 50 represents an untransformed FDR of 0.00001 or 1 
false positive per 100,000 observations. 
All gene ratios are based on reads per kilobase per million reads (RPKM), to correct for gene length 
and total reads per sample, as previously reported [87]. We also developed a novel approach to further 
refine this normalization strategy by employing reads per kilobase per million reads interrogated 
(RPKMI) which replaces the total number of aligned reads with the number of reads matching a list of 
known genes. This novel method corrects for disproportionate intronic and non-genic reads between 
RNA samples, which may be a significant confounder using the RPKM method. This method was used 
to develop read tracks that can be visualized in the Integrated Genome Browser (IGB) [85]. 
We designed custom software to identify enriched KEGG pathways using a Fisher’s exact test and 
display differentially expressed genes at each time-point.  
Unannotated transcripts were identified using the Cufflinks application [31]. Differential expression 
of identified novel regions was determined using the DRSS application as described above. We used 
an RPKM cutoff of 5 for follow-up by qPCR and RACE analysis. 
4.7. Real-Time PCR (qPCR) 
Six mock infected and six HCV infected Huh 7.5 culture specimens were used for further analysis 
of differentially expressed genes at each time point. Total RNA from infected and control hepatocytes 
were extracted using TRIzol. First-strand cDNA was synthesized using Moloney Murine Leukemia 
Virus reverse transcriptase (SuperScript III; Invitrogen) with 20 ng/mL of RNA at 55 °C (60 min) with 
random hexamer primers. Each qPCR reaction was carried out in a 384-well optical plate (Roche 
Applied Science) in a 10 µL reaction buffer containing LightCycler 480 Probes Master Mix (100 mM 
Tris-HCl, 100 mM KCl, 400 mM of each dNTP (with dUTP instead of dTTP), 64 mM MgCl2, 
FastStart Taq DNA Polymerase, 0.3 mM of each primer, 0.1 mM hydrolysis probe and approximately 
50 ng of cDNA (done in triplicate)). Triplicate incubations without template were used as negative 
controls. Thermal cycling was done in a Roche LightCycler 480 System (Roche Applied Science). The 
qPCR thermo cycling was 95 °C for 5 min, 45 cycles at 95 °C for 10 s, 59 °C for 30 s and 72 °C for 1 
second. The relative quantity of each RNA transcript was calculated with the comparative Ct (cycling 
threshold) method using the formula 2ΔCt.  ΔCt represents the difference between target gene 
expression in mock-infected samples and target gene expression in HCV-infected samples. Reference 
genes (GAPDH and β-actin, ACTB) were used as controls and statistical significance was evaluated 
using the Student’s t-test. 
4.8. 5' and 3' RACE Analysis  
To define novel RNA transcript structure from the differentially expressed unannotated regions of 
chromosomes 8, 5' and 3' rapid amplification of cDNA ends (RACE). We designed gene-specific 
primers on the minus and plus strand of five discrete regions (putative exons) on chromosome 8 that 
were found to upregulated in acute HCV infection by RNA-Seq analysis. To verify the chromosome 
location of each RACE PCR product, each PCR product was gel purified and cloned using a Viruses 2012, 4  
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TA  cloning vector. Cloned products were then sequenced with an Applied Biosystems 3130xl 
Genetic Analyzer. 
4.9. RNA Interference 
For transient transfection, chemically synthesized 21-nucleotide sense and antisense RNA 
oligonucleotides against FUT1 and KLHDC7B and control nontargeting (scrambled) RNA were 
purchased from Santa Cruz Biotechnology. Huh 7.5 cells were plated on six-well plates at 150,000 
cells per well and the next day transfected with siRNA at a final concentration of 33 nM per well using 
Lipofectamine
TM 2000 (Invitrogen), according to manufacturer’s protocols. Efficiency of gene 
silencing was verified by real-time PCR. To study the effect of selected gene knock-down on HCV 
production, siRNA transfected cells were infected with JFH-1 at the MOI of 0.5 for two hours at 37 °C, 
then washed with PBS and supplemented with fresh complete DMEM. The cells were then 
continuously cultured to 24, 48, and 72 hours. At each time point, cell-free supernatants and cells were 
harvested for assessment of HCV production (HCV RNA and infectious particles, see below). 
Experiment was done in triplicate and performed two times. Cytotoxicity assays were done under 
conditions that mimicked the siRNA studies. Huh 7.5 cells were plated in 96-well plate, cultured for  
24 hours and transfected with siRNA against FUT1, KLHDC7B or control siRNA. Cells were mock 
infected 24 hours after transfection. Cell supernatants were collected (72 hours after transfection) and 
assayed for cellular toxicity using a lactate dehydrogenase cytotoxicity assay kit, CytoTox-ONE 
(Promega, Madison, WI, USA) according to manufacturer’s recommendations. 
4.10. Quantification of Infectious HCV Virions and HCV RNA 
Viral titers were determined by limiting dilution analysis of culture supernatants, as described 
before [82,88]. Briefly, medium from each sample in the siRNA transfection/JFH-1 infection 
experiments was collected and stored at −20 °C. Cell supernatants were serially diluted 10-fold in 
complete DMEM. Naive Huh 7.5 cells were grown on cover slips in 24-well plates and infected with 
the transfection sample medium for 2h at 37 °C and then supplemented with fresh complete DMEM. 
The level of HCV infection was determined 48 hours post-infection by immunofluorescence staining 
for HCV NS5A.  
For immunofluorescence assay, cells were extensively washed with PBS, fixed with 4% 
paraformaldehyde, and permeabilized with 0.2% Triton X-100. Fixed cells were blocked with 1% 
bovine serum albumin and 1% normal goat serum in PBS. HCV NS5A protein was detected in cells by 
incubation with an NS5A-specific monoclonal antibody and visualized with the secondary goat 
anti-mouse IgG conjugated with Alexa Fluor 594 fluorescein (Invitrogen, 1:1000 dilutions). Cover 
slips were mounted onto slides with DAPI (Vector labs), and the HCV NS5A were visualized by 
fluorescence microscopy (Nikon E400). The viral titer is expressed as focus-forming units per 
milliliter of supernatant (ffu/mL), as determined by the average number of NS5A-positive foci 
detected by immunofluorescence for NS5A. 
For HCV RNA quantification, total cellular RNA was harvested and purified using Trizol Reagent 
(Invitrogen), reverse transcribed to cDNA using SuperScript III; Invitrogen. Real-time PCR was Viruses 2012, 4  
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performed using Universal Probe Library (as described above) and the JFH-1 5'UTR specific primers 
5'-CATGGCGTTAGTATGAGTGTCg-3' and 5'-GGTTCCGCAGACCACTATG-3'. 
5. Conclusions  
RNA sequencing analysis of differentially selected RNAs demonstrated that acute HCV infection 
causes wide-ranging effects on the expression of annotated and unannotated Pol II genes. This 
approach is likely to have general applications in understanding the host response and viral induced 
pathology by more comprehensively examining selected biospecimens. We provide direct evidence, 
using siRNA gene silencing, that FUT1 and KLHDC7B are required for HCV replication and 
production of infectious virus during acute HCV infection.  
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